Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

Abstract Prostate cancer, as one of the most prevalent malignancies in males, exhibits an approximate 5-year survival rate of 95% in advanced stages. A myriad of molecular events and mutations, including the accumulation of oncometabolites, underpin the genesis and progression of this cancer type. D...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Giulia Ambrosini, Marco Cordani, Ali Zarrabi, Sergio Alcon-Rodriguez, Rosa M. Sainz, Guillermo Velasco, Pedro Gonzalez-Menendez, Ilaria Dando
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2024-01-01
Serie:	Cell Communication and Signaling
Soggetti:	Prostate cancer Oncometabolites Epigenetic alterations Cancer stem cells (CSCs) Metabolic Enzymes EMT
Accesso online:	https://doi.org/10.1186/s12964-023-01462-0
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!